Interventional radiologists have long suspected ionizing radiation has detrimental effects on them, including cataracts, radiodermatitis, and hand depilation.
Interventional radiologists have long suspected ionizing radiation has detrimental effects on them, including cataracts, radiodermatitis, and hand depilation. A study published in the European Journal of Radiology provides proof for those suspicions and expands the exposure risks.
The researchers found the lifetime attributable risk and the excess ratio of radio-induced cancers is appreciable for some cases and some forms of cancer, such as leukemia.
Of 700 workers exposed to ionizing radiation sources, six interventional radiologists from the Universitario Le Fe in Valencia, Spain, all of whom showed symptoms of radiation exposure, were included in the study.
The minimum average excess ratio for skin cancer using wrist physical doses is 1.03 x 10-3; the maximum is 5.06 x 10-2. The range the interventional radiologists experienced is lower than the maximum average, so they were not considered to be at increased risk for skin cancer.
The minimum average excess ratio for leukemia using thermoluminescence dosimeters is 7.84 x 10-2; the maximum is 3.36 x 10-1. Using both the thermoluminescence dosimeters and biological dosimetry, the radiologists were found to be at increased risk for leukemia.
This study reminds radiologists of the risks of working with ionizing radiation, which includes an increased risk of leukemia, said Dr. Robert Vogelzang, past president of the Society of Interventional Radiology, and a professor of radiology at Northwestern University in Chicago, Illinois.
“To me, I take away a simple thing,” he said. “We need to do as much as we can to reduce risk because there are statistically relevant data that show an increased risk for some cancers.”
Should interventional radiologists limit the number of procedures they perform due to the risks involved? Yes and no, according to Vogelzang.
“We have so many imaging modalities, we have to always be aware of the dose we’re using and the number of exams we do,” he said. You have to ask always and every time, ‘is this
necessary?’”
The question has to be asked not only for the patient’s sake, but also for any radiation worker-the radiologist, the technologist, and the nurses standing in the rooms, he said. All are exposed to radiation.
“Awareness of that is really what this is about,” he said. “This is a big issue when it comes to worker and patient safety. It’s that simple. To the degree we see effects, [they] can be attributed to the radiation.”
Vogelzang echoed comments made by the study’s authors.
Because of the observed appreciable risk of leukemia and cancer incidence in the group of radiologists, theoretical and practical education is needed. Training for the medical staff in the cardiology/radiology and nuclear medicine departments is needed, they said.
Training in radiological protection for patients and staff should be an integral part of the education of those using interventional techniques. Risks and benefits, including detrimental effects, should be taken into account when new interventional techniques are introduced, they said.
“This study is not going to prevent me from working in a radiation field, but it’s proof radiation has definable risks,” Vogelzang said.
Expanded FDA Approval Allows Use of Pluvicto Prior to Chemotherapy in Patients with mCRPC
March 28th 2025Recent research demonstrated a 59 percent reduced risk of progression or death with the radioligand therapy Pluvicto in comparison to a change of androgen receptor pathway inhibitor (ARPI) for patients with metastatic castration-resistant prostate cancer (mCRPC).
The Reading Room Podcast: Current Perspectives on the Updated Appropriate Use Criteria for Brain PET
March 18th 2025In a new podcast, Satoshi Minoshima, M.D., Ph.D., and James Williams, Ph.D., share their insights on the recently updated appropriate use criteria for amyloid PET and tau PET in patients with mild cognitive impairment.
GE HealthCare to Launch PET MPI Agent Flyrcado at ACC Conference
March 28th 2025The positron emission tomography myocardial perfusion imaging (PET MPI) agent, which offers a significantly higher half-life than other cardiac PET agents, was recently granted pass-through payment status by CMS that will go into effect on April 1, 2025.
New Collaboration Offers Promise of Automating Prior Authorizations in Radiology with AI
March 26th 2025In addition to a variety of tools to promote radiology workflow efficiencies, the integration of the Gravity AI tools into the PowerServer RIS platform may reduce time-consuming prior authorizations to minutes for completion.